Role of Monoclonal Antibodies in the Treatment of Asthma
BACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system. New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have inc...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/183948 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561324853297152 |
|---|---|
| author | Paul M O’Byrne |
| author_facet | Paul M O’Byrne |
| author_sort | Paul M O’Byrne |
| collection | DOAJ |
| description | BACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system. New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have included humanized monoclonal antibodies (hMabs). |
| format | Article |
| id | doaj-art-e3a4bbc86de84b86af1783bd4449470e |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-e3a4bbc86de84b86af1783bd4449470e2025-02-03T01:25:23ZengWileyCanadian Respiratory Journal1198-22412013-01-01201232510.1155/2013/183948Role of Monoclonal Antibodies in the Treatment of AsthmaPaul M O’Byrne0Firestone Institute for Respiratory Health, St Joseph’s Hospital and Department of Medicine, McMaster University, Hamilton, Ontario, CanadaBACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system. New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have included humanized monoclonal antibodies (hMabs).http://dx.doi.org/10.1155/2013/183948 |
| spellingShingle | Paul M O’Byrne Role of Monoclonal Antibodies in the Treatment of Asthma Canadian Respiratory Journal |
| title | Role of Monoclonal Antibodies in the Treatment of Asthma |
| title_full | Role of Monoclonal Antibodies in the Treatment of Asthma |
| title_fullStr | Role of Monoclonal Antibodies in the Treatment of Asthma |
| title_full_unstemmed | Role of Monoclonal Antibodies in the Treatment of Asthma |
| title_short | Role of Monoclonal Antibodies in the Treatment of Asthma |
| title_sort | role of monoclonal antibodies in the treatment of asthma |
| url | http://dx.doi.org/10.1155/2013/183948 |
| work_keys_str_mv | AT paulmobyrne roleofmonoclonalantibodiesinthetreatmentofasthma |